YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells-Reference-Cited by-同舟云学术

YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells

Published:2017-08-07 Issue:8 Volume:12 Page:e0182149
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cheng Chun-Chia^ORCID,Chang Jungshan,Huang Stanley Ching-Cheng,Lin Huan-Chau,Ho Ai-Sheng,Lim Ken-Hong,Chang Chun-Chao,Huang Ling,Chang Yu-Cheng,Chang Yi-Fang,Wu Cheng-Wen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics;CL Arteaga;Cancer Cell,2014

2. The ERBB network: at last, cancer therapy meets systems biology;Y Yarden;Nat Rev Cancer,2012

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;TJ Lynch;N Engl J Med,2004

4. Activating and resistance mutations of the epidermal growth factor receptor (EGFR) gene and non-small cell lung cancer: a clinical reality;A Taus;Arch Bronconeumol,2011

5. YM155 induces EGFR suppression in pancreatic cancer cells;YS Na;PLoS One,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STAT3 mediates cancer stem‐like tumorsphere formation and PD‐L1 expression to contribute radioresistance in HBV‐positive hepatocellular carcinoma;Advances in Digestive Medicine;2024-04-24

2. Stabilization of AMPK/PFKL/RPIA in the Glycolytic Bodies Transduces IL6/STAT3 Signal in Hepatocarcinogenesis;2024-03-04

3. Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells;Cancer Immunology, Immunotherapy;2023-01-23

4. Radiotherapy enhances CXCR3(high) CD8(+) T cells activation through inducing IFNγ-mediated ICAM-1 expression in lung cancer cells;2022-11-02

5. Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8+ T cell activation to eradicate hepatocellular carcinoma;International Immunopharmacology;2022-11